FR2532549B1 - IMMUNOSTIMULANT COMPOSITION COMPRISING A COMBINATION OF THREE ACTIVE COMPONENTS, AN IMMUNOSTIMULANT, AN ANTIHISTAMINIC OR CORTICOIDAL AGENT AND A GANGLIOPLEGIC PRODUCT AND APPLICATION AS A MEDICAMENT - Google Patents

IMMUNOSTIMULANT COMPOSITION COMPRISING A COMBINATION OF THREE ACTIVE COMPONENTS, AN IMMUNOSTIMULANT, AN ANTIHISTAMINIC OR CORTICOIDAL AGENT AND A GANGLIOPLEGIC PRODUCT AND APPLICATION AS A MEDICAMENT

Info

Publication number
FR2532549B1
FR2532549B1 FR8215263A FR8215263A FR2532549B1 FR 2532549 B1 FR2532549 B1 FR 2532549B1 FR 8215263 A FR8215263 A FR 8215263A FR 8215263 A FR8215263 A FR 8215263A FR 2532549 B1 FR2532549 B1 FR 2532549B1
Authority
FR
France
Prior art keywords
immunostimulant
ganglioplegic
product
antihistaminic
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8215263A
Other languages
French (fr)
Other versions
FR2532549A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8215263A priority Critical patent/FR2532549B1/en
Publication of FR2532549A1 publication Critical patent/FR2532549A1/en
Application granted granted Critical
Publication of FR2532549B1 publication Critical patent/FR2532549B1/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

Immunostimulant composition comprising a combination of 1 a first component consisting of at least one immunostimulant, 2 a second component consisting of an antihistaminic or corticoid agent and 3 a third component consisting of a ganglioplegic product. The preferred ganglioplegic product is procaine.
FR8215263A 1982-09-08 1982-09-08 IMMUNOSTIMULANT COMPOSITION COMPRISING A COMBINATION OF THREE ACTIVE COMPONENTS, AN IMMUNOSTIMULANT, AN ANTIHISTAMINIC OR CORTICOIDAL AGENT AND A GANGLIOPLEGIC PRODUCT AND APPLICATION AS A MEDICAMENT Expired FR2532549B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8215263A FR2532549B1 (en) 1982-09-08 1982-09-08 IMMUNOSTIMULANT COMPOSITION COMPRISING A COMBINATION OF THREE ACTIVE COMPONENTS, AN IMMUNOSTIMULANT, AN ANTIHISTAMINIC OR CORTICOIDAL AGENT AND A GANGLIOPLEGIC PRODUCT AND APPLICATION AS A MEDICAMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8215263A FR2532549B1 (en) 1982-09-08 1982-09-08 IMMUNOSTIMULANT COMPOSITION COMPRISING A COMBINATION OF THREE ACTIVE COMPONENTS, AN IMMUNOSTIMULANT, AN ANTIHISTAMINIC OR CORTICOIDAL AGENT AND A GANGLIOPLEGIC PRODUCT AND APPLICATION AS A MEDICAMENT

Publications (2)

Publication Number Publication Date
FR2532549A1 FR2532549A1 (en) 1984-03-09
FR2532549B1 true FR2532549B1 (en) 1985-07-12

Family

ID=9277306

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8215263A Expired FR2532549B1 (en) 1982-09-08 1982-09-08 IMMUNOSTIMULANT COMPOSITION COMPRISING A COMBINATION OF THREE ACTIVE COMPONENTS, AN IMMUNOSTIMULANT, AN ANTIHISTAMINIC OR CORTICOIDAL AGENT AND A GANGLIOPLEGIC PRODUCT AND APPLICATION AS A MEDICAMENT

Country Status (1)

Country Link
FR (1) FR2532549B1 (en)

Also Published As

Publication number Publication date
FR2532549A1 (en) 1984-03-09

Similar Documents

Publication Publication Date Title
ES2058725T3 (en) TRANSDERMIC APPLICATION OF 2-AMINO-6-N-PROPYLAMINE-4,5,6,7-TETRAHIDROBENZOTIAZOL.
DE3786879D1 (en) Bleaching agent compositions, persacuate-glycolate esters and precursors.
DK588487D0 (en) IMPROVED METAL CONTAINING PHARMACEUTICAL AGENTS
DE19375061I2 (en) HEXADECYLPHOSPHOCOLIN-CONTAINING MEDICAMENT WITH ANTITUMORIC EFFECT.
OA07699A (en) Furo- (3,4-c) -pyridine derivatives, their preparation and therapeutic compositions containing these derivatives.
BR9201253A (en) COMPOUND, PROCESS FOR ITS PREPARATION, DIAGNOSTIC OR THERAPEUTIC AGENT AND APPLICATION OF THE MENTIONED COMPOUND
OA07525A (en) Amino-acid derivatives, their preparation and use as well as the compositions containing these derivatives.
DE3160380D1 (en) Substituted 1,2,5-oxadiazole-2-oxides for use as medicaments and medicaments containing them
DE3686022D1 (en) MONOSACCHARIDE CONTAINING COMPOSITION FOR HEALING Wounds.
FR2703995B1 (en) 5-ACYLAMINO 1,2,4-THIADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE3576505D1 (en) 3,4-DIHYDROBENZOPYRANE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
ES8101624A1 (en) Spiroketalins and their applications
FR2532549B1 (en) IMMUNOSTIMULANT COMPOSITION COMPRISING A COMBINATION OF THREE ACTIVE COMPONENTS, AN IMMUNOSTIMULANT, AN ANTIHISTAMINIC OR CORTICOIDAL AGENT AND A GANGLIOPLEGIC PRODUCT AND APPLICATION AS A MEDICAMENT
FR2573657B1 (en) PRODUCT COMPRISING AN ANTIPROGESTOMIMETIC SUBSTANCE AND A UTEROTONIC SUBSTANCE
TR199600117A2 (en) Procedure for substituting benzolsulfonylurea and thiourea, the use of these substances and the use of pharmacy-related substances on the basis of these compositions and the healing agents containing these compounds.
KR890001540A (en) Heart Failure Treatment
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
SE9004169D0 (en) APPLICATION OF PHARMACEUTICAL AND COSMETIC COMPOSITIONS, CONTAINING 1,8-DIHYDROXY-10-PHENYL-9-ANTRON AS ACTIVE INGREDIENT
ES2090170T3 (en) EXPERT COATING AGENT.
PT86665A (en) PROCESS FOR THE PREPARATION OF 14.15-SUBSTITUTED LANOSTEROLS AND OF HYPOCHOLESTEROLEMIC COMPOSITIONS CONTAINING THE SAME
GR3005231T3 (en)
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
NO163187C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,6-NAPHYRIDINE INGREDIENTS.

Legal Events

Date Code Title Description
ST Notification of lapse